Analytical Science
No Single Test Fully Characterizes a Peptide
No single assay establishes every important peptide attribute. Identity, purity, quantity, structure, physical state, and biological activity usually require complementary methods.
Educational content only. Not medical advice.
Identity requires sequence and chemical-form evidence
Intact mass narrows possibilities but may not localize modifications or distinguish isomers. Peptide mapping, tandem mass spectrometry, amino-acid analysis, terminal sequencing, nuclear magnetic resonance, and comparison with standards can add evidence. Disulfide connectivity, cyclization, stereochemistry, counterion, conjugation site, and terminal groups may define distinct entities. The required set depends on molecular complexity and the claims made about the material.
Purity is multidimensional
Chromatography can resolve related substances under one mechanism; capillary electrophoresis can emphasize charge or size differences; mass spectrometry reveals mass-related populations; size-based and particle methods address aggregation. Residual solvents, reagents, metals, host-cell materials, endotoxin, water, and counterions can affect total composition without appearing in a peptide UV trace. A reported percentage needs the method, detector, integration, and basis.
Quantity and potency are not synonyms
Gravimetric material can include water, salts, counterions, and nonpeptide components. Amino-acid analysis, nitrogen, quantitative NMR, or calibrated chromatography may estimate peptide content under defined assumptions. A functional assay measures activity in a biological system, which depends on method variability and may not be specific to intact peptide. High chemical content does not guarantee expected activity, and activity does not prove chemical purity.
Methods must be suitable for their decisions
Specificity, accuracy, precision, range, detection capability, robustness, standards, and system suitability connect an assay to its intended use. Release, stability, comparability, and investigational testing may require different performance. Analysts should preserve raw data, sample history, and versioned methods. A certificate summary without underlying method context is incomplete evidence and cannot support a personal safety or use claim.
Evidence limits
- The necessary analytical package depends on peptide complexity, process, formulation, and intended decision.
- Passing one method cannot compensate for a blind spot in identity, purity, physical state, or activity.
- This page cannot authenticate or qualify a specific commercial or research material.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
U.S. Food and Drug Administration
Q2(R2) Validation of Analytical Procedures
Official current framework for demonstrating that analytical procedures are fit for their intended identity, purity, and quantitative purposes.
Open sourceU.S. Food and Drug Administration and ICH
Q6B Specifications for Biotechnological/Biological Products
Official framework for physicochemical characterization, purity, impurities, quantity, and potency.
Open sourceCommon questions
Does correct molecular mass prove the sequence is correct?
No. Isomers, sequence rearrangements, stereochemical differences, and alternative modification sites may share mass.
Is HPLC purity the same as peptide content?
No. Chromatographic area, peptide mass fraction, water, counterions, and nonchromophoric impurities are different quantities.
Why include a potency assay?
Chemical identity and quantity do not alone establish that the peptide produces the expected functional response in a validated system.
Continue with context
Continue in the evidence workspace
Explore the complete PeptideSchool research workspace to organize sources, compare evidence layers, and follow related peptide science. Premium tools remain educational and do not provide individualized medical guidance.